The global life science analytics market size is estimated to reach USD 16.33 billion by 2030, registering to grow at a CAGR of 7.50% from 2025 to 2030 according to a new report by Grand View Research, Inc. The growing demand to enhance patient care experience and improve clinical outcomes while minimizing rising healthcare expenses is driving the adoption of analytical solutions in the life sciences market. Social media and improving internet connectivity are significantly impacting the demand for analytical solutions. Emerging trends of the digitalization of healthcare and the growing demand for personalized medicine are contributing to the adoption rates. Furthermore, the adoption of big data analytics and the emergence of advanced data mining techniques are bolstering market growth.
The ongoing Covid-19 pandemic exposed the shortcomings of the existing, overburdened healthcare systems, thus driving the demand for analytical solutions. Key players are rapidly making technological advancements to overcome the existing limitations and identify new verticals for growth. For instance, Moderna implemented IBM analytical solutions integrated with cloud computing, artificial intelligence algorithms, and blockchain solutions to successfully roll out their Covid-19 vaccine program.
The services component segment dominated the market in 2024 owing to the growing trend of outsourcing individual or multi-package services in implementing analytical solutions. Life science organizations lack the required expertise and resources, which drives the outsourcing of services from third-party vendors or consulting firms, which positively impacts the growth of the services segment. The descriptive type of analytical solutions led the market in 2021 owing to the growing implementation of descriptive analysis on historic datasets to analyze the current business scenarios. The predictive type segment is expected to grow lucratively over the forecast period owing to the rising adoption of advanced analytics to predict future outcomes and trends.
The sales and marketing support application segment dominated the market in 2024 owing to the rapid adoption of analytical solutions in sales and marketing functionalities of life science organizations to enhance customer responsiveness and improve engagement to achieve higher sales productivity. The research and development application segment is expected to grow significantly owing to the implementation of analytical solutions in the drug discovery and development process and clinical trial management. The growing product pipeline of life science organizations is contributing to the growth of the research and development segment. The on-demand delivery segment led the market in 2021 and is expected to grow lucratively owing to the rising demand for cloud-deployed and web-hosted analytical solutions with higher ease of access from remotest locations.
The pharmaceutical end-user segment dominated the market in 2024 owing to the rising adoption rates of analytical solutions in improving drug discovery processes and enhancing the efficiency of clinical trials. The biotechnology end-user segment is expected to register the fastest growth rate over the forecast period owing to the adoption of analytical solutions in genome sequencing and analysis. In 2021, North America dominated the market owing to advanced digital literacy, adequate healthcare IT infrastructure, the presence of key players, and high economic development. Asia Pacific is expected to grow lucratively owing to the emergence of startups, favorable funding options, supportive government initiatives, growing healthcare IT expenditure, and the easy availability of high-skilled and low-cost personnel.
Request a free sample copy or view report summary: Life Science Analytics Market Report
The services segment held the largest revenue share of 57.66% in 2024 and is expected to grow fastest for the forecast period.
The descriptive analytics segment held the largest revenue share in the market in 2024 due to its crucial role in summarizing historical data and generating actionable insights.
The sales and marketing support segment held the largest revenue share in 2024 due to its critical role in optimizing product positioning, targeting, and campaign effectiveness.
The on-demand segment held the largest revenue share in 2024 and is expected to grow at the fastest CAGR for the forecast period.
Grand View Research has segmented the global life science analytics market based on component, type, application, delivery, end use, and region:
Life Science Analytics Component Outlook (Revenue, USD Million, 2018 - 2030)
Software
Services
Life Science Analytics Type Outlook (Revenue, USD Million, 2018 - 2030)
Reporting
Descriptive
Predictive
Prescriptive
Life Science Analytics Application Outlook (Revenue, USD Million, 2018 - 2030)
Research and Development
Sales and Marketing Support
Regulatory Compliance
Supply Chain Analytics
Pharmacovigilance
Life Science Analytics Delivery Outlook (Revenue, USD Million, 2018 - 2030)
On-demand
On-premise
Life Science Analytics End Use Outlook (Revenue, USD Million, 2018 - 2030)
Medical Devices
Pharmaceutical
Biotechnology
Genomics
Others
Life Science Analytics Regional Outlook (Revenue, USD Million, 2018-2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Sweden
Denmark
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East and Africa
Saudi Arabia
South Africa
UAE
Kuwait
List of Key Players in Life Science Analytics Market
Oracle
IQVIA
SAS Institute Inc.
Cognizant
IBM
Accenture
Take Solutions Limited
Wipro Limited
Veradigm
Optum
Veeva Systems
Axtria
Komoda Health, Inc.
Elsevier
"The quality of research they have done for us has been excellent..."